Images of the brain's fastest signals reveal an electromagnetic marker that predicts a patient's retroaction to a fast-acting antidepressant, researchers have discovered. "Such biomarkers that name who will benefit from a new class of antidepressants could someday minimize trial-and-error prescribing and speed elocution of care for what can be a life-threatening illness," said Carlos Zarate, M.

More: - Brought to my attention by